The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,860.00
Bid: 1,860.00
Ask: 1,872.00
Change: -8.00 (-0.43%)
Spread: 12.00 (0.645%)
Open: 1,830.00
High: 1,890.00
Low: 1,830.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

National Milk Records plc - Form 8.3

16 Jun 2023 17:33

RNS Number : 0620D
Genus PLC
16 June 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Genus plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

National Milk Records plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

16th June 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,120,000

9.98

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

2,120,000

9.98

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

16 June 2023

Contact name:

Dan Hartley

Telephone number*:

01256 345970

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUNONROUUNAAR
Date   Source Headline
12th Oct 20184:37 pmRNSDirector/PDMR Shareholding
1st Oct 20182:00 pmRNSTotal Voting Rights
24th Sep 20186:01 pmRNSAdditional Listing
24th Sep 20181:52 pmRNSNon-Executive Director Retirement
19th Sep 20183:36 pmRNSDirector/PDMR Shareholding
18th Sep 20185:21 pmRNSDirector/PDMR Shareholding
17th Sep 20185:27 pmRNSDirector/PDMR Shareholding
6th Sep 20187:00 amRNSPreliminary Results
1st Aug 20182:00 pmRNSBlock listing Interim Review
20th Jul 201811:56 amRNSHolding(s) in Company
11th Jul 20181:44 pmRNSHolding(s) in Company
9th Jul 20187:00 amRNSHolding(s) in Company
20th Jun 20187:00 amRNSCapital Markets Event
12th Jun 20182:42 pmRNSDirector/PDMR Shareholding
24th May 20187:00 amRNSBoard Appointment
18th May 20185:22 pmRNSDirector/PDMR Shareholding
1st May 20184:39 pmRNSTotal Voting Rights
12th Apr 20186:18 pmRNSDirector/PDMR Shareholding
16th Mar 20182:34 pmRNSDirector/PDMR Shareholding
5th Mar 20186:38 pmRNSDirector/PDMR Shareholding
1st Mar 201810:48 amRNSHolding(s) in Company
28th Feb 20187:00 amRNSInterim Results
1st Feb 20182:00 pmRNSBlock listing Interim Review
29th Dec 201711:51 amRNSDirector/PDMR Shareholding
22nd Dec 201711:27 amRNSDirector/PDMR Shareholding
13th Dec 20175:48 pmRNSDirector/PDMR Shareholding
8th Dec 20174:41 pmRNSDirector/PDMR Shareholding
1st Dec 20172:00 pmRNSTotal Voting Rights
23rd Nov 201710:57 amRNSDirector/PDMR Shareholding
17th Nov 20172:15 pmRNSAdditional Listing to Correct Discrepancy
16th Nov 20172:49 pmRNSResult of AGM
16th Nov 20177:00 amRNSAGM Trading Update
6th Nov 201712:48 pmRNSDirector/PDMR Shareholding
2nd Nov 20172:01 pmRNSNon-Executive Director Retirement
1st Nov 20172:00 pmRNSTotal Voting Rights
31st Oct 20177:00 amRNSAdditional Listing
12th Oct 201710:39 amRNSNotice of AGM
2nd Oct 20172:00 pmRNSTotal Voting Rights
29th Sep 20177:08 amRNSDirector Declaration
21st Sep 20175:29 pmRNSDirector/PDMR Shareholding - Replacement
14th Sep 20175:30 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSPreliminary Results
1st Sep 20173:12 pmRNSTotal Voting Rights
17th Aug 20172:51 pmRNSHolding(s) in Company
1st Aug 20172:00 pmRNSBlock listing Interim Review
1st Aug 20172:00 pmRNSTotal Voting Rights
3rd Jul 20172:59 pmRNSTotal Voting Rights
29th Jun 20175:23 pmRNSAdditional Listing
12th Jun 20173:23 pmRNSHolding(s) in Company
9th Jun 20177:00 amRNSUS LITIGATION UPDATE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.